I am an assistant attending physicist and assistant clinical member in the Department of Medical Physics and Director of Mechanical Engineering and Instrumentation in Biomedical Engineering. I am responsible for the design and fabrication of patient-specific and specialty medical devices produced within the Instrument Shop, Block Shop, and 3D Printing Laboratory in Biomedical Engineering. My team supports multiple clinical groups and research groups with a broad range of engineering and design services. I also investigate new and emerging technologies that have the potential to enhance clinical applications and operational workflow.
I have a background in experimental fluid dynamics, thermodynamics, instrumentation, mechanical design, scientific imaging, and optics. I have experience designing a broad range of mechanical systems and instrumentation for use in research and production environments. I received a PhD in mechanical engineering from the University of North Carolina at Charlotte in 2012.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Samuel Hellman discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures